December 23, 2019

In what could have been the policy hallmark of his first term in office, President Trump originally honored his promise to voters and renegotiated the outdated North American Free Trade Agreement (NAFTA) in the form of the new United States-Mexico-Canada Agreement (USMCA).

SEE CASE TV AD HERE:

Despite being signed by all three countries in November of 2018 and enjoying bipartisan support in Congress, Speaker of the House Nancy Pelosi stalled official ratification of the agreement for over a year.

In what can only be described as a handout to socialist neighbors like Canada, she then stripped out what makes this trade agreement so strong, critical intellectual property (IP) protections on a new form of medicine called biologics. The deal as written by the Trump administration included ten years of protection of American IP overseas, but, of course, Canada and Mexico would love to see that significantly lowered so they can reap the benefits of American innovation without paying for it.

These are the same leaders who openly mock our President on the world stage and have shown no regard for US interests, consumers, or innovation.

 

This foreign freeloading needs to stop. American workers and businesses poured billions of dollars and thousands of hours into creating these medicines, and their property needs to be protected.

Make no mistake, the fact that President Trump’s trade deal took over a year to be ratified only to be re-written under the Democrats’ agenda has no roots in policy. It is a partisan political effort by Democrats to tarnish the President’s record on the backs of American researchers and workers.

Despite the very real threat of lost jobs, less medical investment, fewer cures, and being taken advantage of by the rest of the world, the Trump administration unfortunately let the leftists re-write a good deal.